These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23539745)

  • 41. Genetic alterations in methicillin-susceptible Staphylococcus aureus associated with high vancomycin minimum inhibitory concentration.
    Kang YR; Chung DR; Ko JH; Huh K; Cho SY; Kang CI; Peck KR
    Int J Antimicrob Agents; 2023 Dec; 62(6):106971. PubMed ID: 37716577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
    Camargo IL; Neoh HM; Cui L; Hiramatsu K
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4289-99. PubMed ID: 18824611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
    Rio-Marques L; Hartke A; Bizzini A
    Microb Drug Resist; 2014 Dec; 20(6):539-43. PubMed ID: 25010140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB
    Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
    Hafer C; Lin Y; Kornblum J; Lowy FD; Uhlemann AC
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5845-51. PubMed ID: 22948864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Dilworth TJ; Leonard SN; Vilay AM; Mercier RC
    Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vancomycin MICs of the resistant mutants of S. aureus ATCC43300 vary based on the susceptibility test methods used.
    Zhu YL; Mei Q; Hu LF; Cheng J; Ye Y; Li JB
    J Antibiot (Tokyo); 2012 Jun; 65(6):307-10. PubMed ID: 22491134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nemonoxacin Enhances Antibacterial Activity and Anti-Resistance Mutation Ability of Vancomycin against Methicillin-Resistant Staphylococcus aureus in an
    Huang J; Guo S; Li X; Yuan F; Li Y; Xu B; Gu J; Qiao Y
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0180021. PubMed ID: 34902266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a Single-nucleotide Polymorphism Genotyping Assay for the Rapid Detection of Vancomycin-intermediate Resistance in
    Kim JW; Lee KJ
    Ann Lab Med; 2023 Jul; 43(4):355-363. PubMed ID: 36843404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
    Cesur S; Irmak H; Simşek H; Cöplü N; Kılıç H; Arslan U; Bayramoğlu G; Baysan BO; Gülay Z; Hoşoğlu S; Berktaş M; Gencer S; Demiröz AP; Esen B; Karabiber N; Aydın F; Yalçın AN
    Mikrobiyol Bul; 2012 Jul; 46(3):352-8. PubMed ID: 22951647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.
    Okado JB; Avaca-Crusca JS; Oliveira AL; Dabul ANG; Camargo ILBDC
    J Glob Antimicrob Resist; 2018 Sep; 14():209-216. PubMed ID: 29753135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of subinhibitory concentration of chlorhexidine on the evolution of vancomycin-intermediate Staphylococcus aureus and the induction of mutations in walKR and vraTSR systems.
    Baseri N; Najar-Peerayeh S; Bakhshi B
    Infect Genet Evol; 2021 Jan; 87():104628. PubMed ID: 33171303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and genotypic relatedness of methicillin resistant Staphylococcus aureus in a tertiary care hospital.
    Fomda BA; Thokar MA; Bashir G; Khan A; Kour A; Zahoor D; Ray P
    J Postgrad Med; 2014; 60(4):386-9. PubMed ID: 25370547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
    Lin SY; Chen TC; Chen FJ; Chen YH; Lin YI; Siu LK; Lu PL
    J Microbiol Immunol Infect; 2012 Dec; 45(6):435-41. PubMed ID: 22749725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacodynamics of a simulated single 1,200-milligram dose of oritavancin in an in vitro pharmacokinetic/pharmacodynamic model of methicillin-resistant staphylococcus aureus infection.
    Belley A; Arhin FF; Sarmiento I; Deng H; Rose W; Moeck G
    Antimicrob Agents Chemother; 2013 Jan; 57(1):205-11. PubMed ID: 23089749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.
    Passalacqua KD; Satola SW; Crispell EK; Read TD
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5212-23. PubMed ID: 22850507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
    Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
    Mishra NN; Yang SJ; Sawa A; Rubio A; Nast CC; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2312-8. PubMed ID: 19332678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rifampicin resistance among multi-resistant MRSA clinical isolates from Chennai, India, and their molecular characterization.
    Murugan K; Kavitha K; Al-Sohaibani S
    Genet Mol Res; 2015 Mar; 14(1):2716-25. PubMed ID: 25867420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.